Novo Nordisk Inc. et al v. Biocon Pharma Ltd. et al
| Novo Nordisk Inc. and Novo Nordisk A/S |
| Biocon Pharma Ltd., Biocon Ltd. and Biocon Pharma, Inc. |
| 1:2022cv00936 |
| July 14, 2022 |
| US District Court for the District of Delaware |
| Colm F Connolly |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on August 22, 2022. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 11 MOTION for Pro Hac Vice Appearance of Attorney Jeffrey J. Oelke, Ryan P. Johnson, Robert E. Counihan, Laura T. Moran, Erica R. Sutter and Olivia L. Wheeling - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Egan, Brian) |
SO ORDERED, re (11 in 1:22-cv-00936-CFC, 8 in 1:22-cv-00856-CFC, 11 in 1:22-cv-00937-CFC, 9 in 1:22-cv-00896-CFC, 9 in 1:22-cv-00897-CFC) MOTION for Pro Hac Vice Appearance of Attorney Jeffrey J. Oelke, Ryan P. Johnson, Robert E. Counihan, Laura T. Moran, Erica R. Sutter and Olivia L. Wheeling, filed by Novo Nordisk A/S, Novo Nordisk Inc. Ordered by Judge Colm F. Connolly on 8/22/2022. Associated Cases: 1:22-cv-00856-CFC, 1:22-cv-00896-CFC, 1:22-cv-00897-CFC, 1:22-cv-00936-CFC, 1:22-cv-00937-CFC(kmd)
|
| Filing 10 WAIVER OF SERVICE returned executed by Novo Nordisk Inc., Novo Nordisk A/S: For Biocon Pharma Ltd. waiver sent on 7/21/2022, answer due 9/19/2022. (Egan, Brian) |
| Filing 9 WAIVER OF SERVICE returned executed by Novo Nordisk Inc., Novo Nordisk A/S: For Biocon Pharma, Inc. waiver sent on 7/21/2022, answer due 9/19/2022. (Egan, Brian) |
| Filing 8 WAIVER OF SERVICE returned executed by Novo Nordisk Inc., Novo Nordisk A/S: For Biocon Ltd. waiver sent on 7/21/2022, answer due 9/19/2022. (Egan, Brian) |
| Filing 7 MOTION for Pro Hac Vice Appearance of Attorney Matthew M. Holub, Attorney Jitendra "Jitty" Malik, Attorney Deepro R. Mukerjee and Attorney Lance A. Soderstrom - filed by Biocon Ltd., Biocon Pharma Ltd., Biocon Pharma, Inc.. (Dorsney, Kenneth) |
| Pro Hac Vice Attorney Matthew M. Holub, Jitendra M. Malik, Deepro R. Mukerjee, and Lance A. Soderstrom for Biocon Ltd., Biocon Pharma Ltd., and Biocon Pharma, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
|
SO ORDERED, re #7 MOTION for Pro Hac Vice Appearance of Attorney Matthew M. Holub, Attorney Jitendra "Jitty" Malik, Attorney Deepro R. Mukerjee and Attorney Lance A. Soderstrom, filed by Biocon Pharma, Inc., Biocon Ltd., Biocon Pharma Ltd. Ordered by Judge Colm F. Connolly on 7/22/2022. (kmd)
|
| Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:22-cv-00936-CFC, 1:22-cv-00937-CFC (rjb) |
| Filing 6 Summons Issued as to Biocon Ltd., Biocon Pharma Ltd., Biocon Pharma, Inc. on 7/15/2022. (Attachments: #1 Summons - Biocon Pharma, Inc., #2 Summons - Biocon Pharma Ltd.)(twk) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novo Nordisk US Holdings, Inc. for Novo Nordisk Inc.; Corporate Parent Novo A/S, Other Affiliate Novo Nordisk US Holdings Inc. for Novo Nordisk A/S filed by Novo Nordisk A/S, Novo Nordisk Inc.. (twk) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,762,994 B2; 8,114,883 B2; 9,265,893 B2. (twk) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: June 11, 2022. Date of Expiration of Patent: U.S. Patent No. 7,762,994 expires on 11/23/2024 with PED; U.S. Patent No. 8,114,833 expires on 2/13/2026 with PED; and U.S. Patent No. 9,265,893 expires on 3/23/2033 with PED. Thirty Month Stay Deadline: 12/11/2024. (twk) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (twk) |
| Filing 1 COMPLAINT filed against Biocon Ltd., Biocon Pharma Ltd., Biocon Pharma, Inc. ( Filing fee $ 402, receipt number ADEDC-3915660.) - filed by Novo Nordisk Inc., Novo Nordisk A/S. (Attachments: #1 Exhibit A-C, #2 Civil Cover Sheet)(twk) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
